Advisory Services Network’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Advisory Services Network’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$93.1K	Buy	+1,176	New	+$95.1K	﹤0.01%	2250
2025 Q4	–	Sell	-1,173	Closed	-$82K	–	3531
2025 Q3	$82K	Buy	+1,173	New	+$79.3K	﹤0.01%	2178
2024 Q1	–	Sell	-1,550	Closed	-$102K	–	2999
2023 Q4	$102K	Buy	+1,550	New	+$90.1K	﹤0.01%	1637
2023 Q2	–	Sell	-1,560	Closed	-$97.9K	–	2983
2023 Q1	$97.9K	Hold	1,560	–	–	﹤0.01%	1660
2022 Q4	$99.1K	Buy	+1,560	New	+$99K	﹤0.01%	1627
2021 Q3	–	Sell	-231	Closed	-$18K	–	2680
2021 Q2	$18K	Buy	+231	New	+$17.2K	﹤0.01%	2552
2021 Q1	–	Sell	-231	Closed	-$16K	–	2464
2020 Q4	$16K	Hold	231	–	–	﹤0.01%	2232
2020 Q3	$13K	Buy	+231	New	+$13.6K	﹤0.01%	2289
2020 Q2	–	Sell	-231	Closed	-$11K	–	2228
2020 Q1	$11K	Buy	231 +90	+64%	+$4.69K	﹤0.01%	2175
2019 Q4	$8K	Sell	141 -35	-20%	-$1.82K	﹤0.01%	2452
2019 Q3	$9K	Hold	176	–	–	﹤0.01%	2212
2019 Q2	$9K	Hold	176	–	–	﹤0.01%	2210
2019 Q1	$10K	Hold	176	–	–	﹤0.01%	1851
2018 Q4	$8K	Hold	176	–	–	﹤0.01%	1851
2018 Q3	$10K	Hold	176	–	–	﹤0.01%	1813
2018 Q2	$10K	Hold	176	–	–	﹤0.01%	1796
2018 Q1	$9K	Hold	176	–	–	﹤0.01%	1913
2017 Q4	$8K	Buy	176 +102	+138%	+$4.78K	﹤0.01%	1926
2017 Q3	$4K	Sell	74 -82	-53%	-$3.89K	﹤0.01%	1982
2017 Q2	$7K	Buy	156 +82	+111%	+$3.54K	﹤0.01%	1687
2017 Q1	$3K	Buy	+74	New	+$3.1K	﹤0.01%	1896
2016 Q3	$30K	Buy	723 +73	+11%	+$3K	0.01%	1020
2016 Q2	$24K	Buy	650 +460	+242%	+$18K	0.01%	980
2016 Q1	$7K	Hold	190	–	–	﹤0.01%	1174
2015 Q4	$10K	Buy	190 +1	+0.5%	+$49	﹤0.01%	940
2015 Q3	$9K	Sell	189 -1,737	-90%	-$97.1K	﹤0.01%	947
2015 Q2	$112K	Buy	1,926 +1	+0.1%	+$57	0.03%	360
2015 Q1	$107K	Hold	1,925	–	–	0.03%	373
2014 Q4	$103K	Buy	+1,925	New	+$94.2K	0.03%	332

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Advisory Services Network's PBE Position: Q1 2026 in Review

Advisory Services Network opened a new position in Invesco Biotechnology & Genome ETF (PBE) in Q1 2026: 1,176 shares worth $93.1K. The stake represents ﹤0.01% of the portfolio and ranks #2250 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in PBE as recently as Q3 2025.

Advisory Services Network first reported a position in PBE in Q4 2014 and has held it in 29 quarters since. The position peaked at $112K in Q2 2015. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

Advisory Services Network held 1,176 shares of Invesco Biotechnology & Genome ETF worth $93.1K as of Q1 2026.
Invesco Biotechnology & Genome ETF was a new Advisory Services Network position in Q1 2026.
Invesco Biotechnology & Genome ETF made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2250 holding.
Advisory Services Network first reported a position in Invesco Biotechnology & Genome ETF in Q4 2014 and has held it in 29 quarters since.
Advisory Services Network's Invesco Biotechnology & Genome ETF position peaked at $112K in Q2 2015.
100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.